TNFRSF4 and neuroblastoma: Patients with a progression event such as metastasis or relapse also exhibited significantly lower TNFRSF4 expression (N = 183), and finally, TNFRSF4 expression was significantly lower in patients who died from neuroblastoma (N = 105) (Fig 4C).